Bone Scintigraphy and Unicompartimental Knee Arthroplasty

Bone Scintigraphy and Knee Arthroplasty Clinical Trial

— PUC-INTEVO  

Official title:

Interest of Bone Scintigraphy in Pre-operative Assessment of Knee Osteoarthritis in Patients Undergoing Unicompartmental Knee Arthroplasty

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03145090
• Other study ID #: PUC-INTEVO (29BRC17.0027)
• Status: Active, not recruiting
• Start date: March 16, 2017
• Est. completion date: October 11, 2019

Study information

• Verified date: July 2018
• Source: University Hospital, Brest
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Study the potential interest of bone scintigraphy for patients undergoing unicompartmental knee arthroplasty

Description:

Knee osteoarthritis is a very common disease with significant functional consequences. Surgical treatment is the ultimate treatment with the possibility of replacing only one compartment or the 3 joint compartments.

Consequently, the pre-surgical imaging is essential to ensure that the 3 compartments are not compromised when a uni-compartmental prosthesis (PUC) is considered.

The scintigraphy because of its good diagnostic performance seems to be interesting in this indication for the preoperative assessment of knee uni-compartmental prostheses to ensure the absence of degenerative lesion of the unoperated compartment.

This study will evaluate the impact of bone scintigraphy on surgery and the potential correlation between scintigraphic and clinical data; study the pronostic impact of bone scintigraphy

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 100
• Est. completion date: October 11, 2019
• Est. primary completion date: September 16, 2017
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patient over 18 years old / uni or bilateral unicompartmental knee prothesis/ non opposition

Exclusion Criteria:

• Under 18 years old/ contraindications for bone scintigraphy/ refusal to participate

Related Conditions & MeSH terms

• Bone Scintigraphy and Knee Arthroplasty

Locations

Country	Name	City	State
France	CHRU de Brest	Brest
France	Clinique de La Baie	Morlaix

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	modification in surgical strategy according to bone scintigraphy results	pourcentage of therapeutic modification according to bone scintigraphy results	18 months